Hatami, Behzad

Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial

Saadati, S., Sadeghi, A., Mansour, A., Yari, Z., Poustchi, H., Hedayati, M., Hatami, B., & Hekmatdoost, A. (2019) · BMC Gastroenterology

Curcumin's Biomedical ApplicationsLiver Disease Diagnosis and Treatment

Cited by 164

The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease

Saadati, S., Hatami, B., Yari, Z., Shahrbaf, M. A., Eghtesad, S., Mansour, A., Poustchi, H., Hedayati, M., Aghajanpoor-pasha, M., Sadeghi, A., et al. (2019) · European Journal of Clinical Nutrition

Curcumin's Biomedical ApplicationsLiver Disease Diagnosis and Treatment

Cited by 110

Obeticholic acid-loaded exosomes attenuate liver fibrosis through dual targeting of the FXR signaling pathway and ECM remodeling

Azizsoltani, A., Hatami, B., Zali, M. R., Mahdavi, V., Baghaei, K., & Alizadeh, E. (2023) · Biomedicine & Pharmacotherapy

Extracellular vesicles in diseaseLiver physiology and pathology

Cited by 40

Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis

Mazhari, S., Gitiara, A., Baghaei, K., Hatami, B., Rad, R. E., Asadirad, A., Joharchi, K., Tokhanbigli, S., Hashemi, S. M., Łos, M. J., et al. (2020) · European Journal of Pharmacology

Liver physiology and pathologyMesenchymal stem cell research

Cited by 22

The effect of mesenchymal stem cells and imatinib on macrophage polarization in rat model of liver fibrosis

Malmir, A., Farivar, S., Rezaei, R., Tokhanbigli, S., Hatami, B., Mazhari, S., & Baghaei, K. (2023) · Cell Biology International

Liver physiology and pathologyMesenchymal stem cell research

Cited by 6